Table 3.
Secondary outcome measures in children with recurrent acute otitis media randomised to receive adenoidectomy, prophylaxis with sulfafurazole, or placebo*
|
Adenoidectomy
|
Sulfafurazole
|
Mean (SD) on placebo
|
|||
|---|---|---|---|---|---|
| Measure | Mean (SD) | Difference in mean†(95% CI) | Mean (SD) | Difference in mean†(95% CI) | |
| Episodes of acute otitis media | 1.3 (0.9) | 0.0 (−0.4 to 0.4) | 1.0 (0.8) | 0.3 (−0.1 to 0.6) | 1.3 (0.9) |
| Sick child visits | 3.3 (1.8) | 0.6 (−0.3 to 1.5) | 3.7 (2.0) | 0.2 (−0.7 to 1.1) | 3.9 (2.4) |
| Antimicrobial prescriptions | 1.5 (1.1) | −0.1 (−0.6 to 0.5) | 1.4 (1.3) | 0 (−0.5 to 0.6) | 1.4 (1.2) |
| Days with rhinitis | 26 (23) | −4 (−13 to 7) | 23 (24) | 0 (−10 to 10) | 23 (25) |
| Days with earache | 1.9 (3.1) | −0.3 (−1.6 to 1.0) | 1.7 (3.4) | −0.1 (−1.4 to 1.2) | 1.6 (2.4) |
| Days with fever | 5.3 (8.2) | −1.6 (−4.5 to 1.2) | 4.8 (6.7) | −1.1 (−3.9 to 1.8) | 3.7 (4.3) |
*
Analysed until intervention failure, drop out, or six months of follow up, whichever came first.
†
Compared with placebo.